
|Articles|April 11, 2022
Komodo Health and Datavant Expand Partnership
Collaboration reinforces value of connecting proprietary and third-party data.
Advertisement
Komodo Health and Datavant announced an expansion of their partnership. Together, they will enable life sciences companies to securely connect proprietary and third-party clinical trial data, specialty pharmacy data, and more to Komodo’s technology and insights platform.
Read more about the partnership expansion
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
The GLP-1 Gold Rush
5





